139 related articles for article (PubMed ID: 15249740)
1. Inhibition of growth hormone secretion in mild primary hyperparathyroidism.
Coiro V; Volpi R; Capretti L; Finardi L; Magotti MG; Manfredi G; Chiodera P; Saccani Jotti G
Horm Res; 2004; 62(2):88-91. PubMed ID: 15249740
[TBL] [Abstract][Full Text] [Related]
2. GH secretion is impaired in patients with primary hyperparathyroidism.
Gasperi M; Cecconi E; Grasso L; Bartalena L; Centoni R; Aimaretti G; Broglio F; Miccoli P; Marcocci C; Ghigo E; Martino E
J Clin Endocrinol Metab; 2002 May; 87(5):1961-4. PubMed ID: 11994325
[TBL] [Abstract][Full Text] [Related]
3. Primary hyperparathyroidism is associated with marked impairment of GH response to acylated ghrelin.
Cecconi E; Bogazzi F; Morselli LL; Gasperi M; Procopio M; Gramaglia E; Broglio F; Giovannetti C; Ghigo E; Martino E
Clin Endocrinol (Oxf); 2008 Aug; 69(2):197-201. PubMed ID: 18221398
[TBL] [Abstract][Full Text] [Related]
4. The reduction of bone mineral density in postmenopausal women with primary hyperparathyroidism is higher in the presence of concomitant GH secretion impairment.
Cecconi E; Gasperi M; Genovesi M; Bogazzi F; Grasso L; Cetani F; Procopio M; Marcocci C; Bartalena L; Martino E
Eur J Endocrinol; 2006 Jul; 155(1):41-5. PubMed ID: 16793948
[TBL] [Abstract][Full Text] [Related]
5. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
6. Growth hormone (GH) responses to GH-releasing hormone alone or combined with arginine in patients with adrenal incidentaloma: evidence for enhanced somatostatinergic tone.
Terzolo M; Bossoni S; Alí A; Doga M; Reimondo G; Milani G; Peretti P; Manelli F; Angeli A; Giustina A
J Clin Endocrinol Metab; 2000 Mar; 85(3):1310-5. PubMed ID: 10720081
[TBL] [Abstract][Full Text] [Related]
7. Marked GH secretion after ghrelin alone or combined with GH-releasing hormone (GHRH) in obese patients.
Alvarez-Castro P; Isidro ML; Garcia-Buela J; Leal-Cerro A; Broglio F; Tassone F; Ghigo E; Dieguez C; Casanueva FF; Cordido F
Clin Endocrinol (Oxf); 2004 Aug; 61(2):250-5. PubMed ID: 15272922
[TBL] [Abstract][Full Text] [Related]
8. Immunoreactive growth hormone-releasing hormone (IR-GHRH) in the feto-placental circulation and differential effects of L-dopa, L-arginine and somatostatin-14 on the plasma levels of IR-GHRH in normal adults.
Saito H; Hosoi E; Yamasaki R; Kameyama K; Irahara M; Ohno Y; Saito S
Horm Metab Res; 1997 Apr; 29(4):184-9. PubMed ID: 9178029
[TBL] [Abstract][Full Text] [Related]
9. Cranially irradiated adult cancer survivors may have normal spontaneous GH secretion in the presence of discordant peak GH responses to stimulation tests (compensated GH deficiency).
Darzy KH; Thorner MO; Shalet SM
Clin Endocrinol (Oxf); 2009 Feb; 70(2):287-93. PubMed ID: 18673465
[TBL] [Abstract][Full Text] [Related]
10. Growth hormone secretion in primary and secondary hyperparathyroidism.
Cecconi E; Gasperi M; Genovesi M; Bogazzi F; Grasso L; Procopio M; Marcocci C; Pinchera A; Bartalena L; Martino E
J Endocrinol Invest; 2005 Feb; 28(2):113-6. PubMed ID: 15887855
[TBL] [Abstract][Full Text] [Related]
11. GH response to GHRH combined with pyridostigmine or arginine in different conditions of low somatotrope secretion in adulthood: obesity and Cushing's syndrome in comparison with hypopituitarism.
Procopio M; Maccario M; Savio P; Valetto MR; Aimaretti G; Grottoli S; Oleandri SE; Baffoni C; Tassone F; Arvat E; Camanni F; Ghigo E
Panminerva Med; 1998 Mar; 40(1):13-7. PubMed ID: 9573747
[TBL] [Abstract][Full Text] [Related]
12. Effects of beta-adrenergic agonists and antagonists on the growth hormone response to growth hormone-releasing hormone in anorexia nervosa.
Gianotti L; Arvat E; Valetto MR; Ramunni J; Di Vito L; Maccagno B; Camanni F; Ghigo E
Biol Psychiatry; 1998 Feb; 43(3):181-7. PubMed ID: 9494699
[TBL] [Abstract][Full Text] [Related]
13. Growth hormone secretion among HIV infected patients: effects of gender, race and fat distribution.
Koutkia P; Eaton K; You SM; Breu J; Grinspoon S
AIDS; 2006 Apr; 20(6):855-62. PubMed ID: 16549969
[TBL] [Abstract][Full Text] [Related]
14. Repeated administration of growth hormone-releasing hormone with or without previous administration of pyridostigmine in insulin-dependent diabetes mellitus.
Martina V; Bruno G; Tagliabue M; Maccario M; Bertaina S; Zumpano E; Arvat E; Ghigo E; Camanni F
Horm Metab Res; 1997 Apr; 29(4):180-3. PubMed ID: 9178028
[TBL] [Abstract][Full Text] [Related]
15. Effects of growth hormone administration on bone mineral metabolism, PTH sensitivity and PTH secretory rhythm in postmenopausal women with established osteoporosis.
Joseph F; Ahmad AM; Ul-Haq M; Durham BH; Whittingham P; Fraser WD; Vora JP
J Bone Miner Res; 2008 May; 23(5):721-9. PubMed ID: 18052753
[TBL] [Abstract][Full Text] [Related]
16. Improvement of growth hormone deficiency in patients with primary hyperparathyroidism after parathyroidectomy: results of a prospective study.
Cecconi E; Gasperi M; Bogazzi F; Grasso L; Genovesi M; Marcocci C; Pinchera A; Procopio M; Bartalena L; Martino E
J Clin Endocrinol Metab; 2004 Mar; 89(3):1213-6. PubMed ID: 15001612
[TBL] [Abstract][Full Text] [Related]
17. The dependency of calcium set point on basal plasma calcium in dialysis patients: a better explanation for the discrepancies regarding its link with PTH secretion than methodological differences.
Hardy-Yverneau P; Shenouda M; Moriniere P; Legallais C; Brazier M; Achard J; Fournier A
Clin Nephrol; 1998 Oct; 50(4):236-46. PubMed ID: 9799069
[TBL] [Abstract][Full Text] [Related]
18. Impaired GH secretion to provocative stimuli in two families with hypocalciuric hypercalcaemia.
Cecconi E; Bogazzi F; Cetani F; Grasso L; Marcocci C; Genovesi M; Procopio M; Gasperi M; Pinchera A; Ghigo E; Martino E
Clin Endocrinol (Oxf); 2003 Nov; 59(5):604-6. PubMed ID: 14616884
[TBL] [Abstract][Full Text] [Related]
19. Direct in vivo comparison of calcium-regulated parathyroid hormone secretion in normal volunteers and patients with secondary hyperparathyroidism.
Ramirez JA; Goodman WG; Gornbein J; Menezes C; Moulton L; Segre GV; Salusky IB
J Clin Endocrinol Metab; 1993 Jun; 76(6):1489-94. PubMed ID: 8501155
[TBL] [Abstract][Full Text] [Related]
20. Primary hyperparathyroidism is associated with an impaired secretion of growth hormone but not of the other anterior pituitary hormones.
Cecconi E; Gasperi M; Grasso L; Genovesi M; Aimaretti G; Broglio F; Bartalena L; Marcocci C; Martino E
J Endocrinol Invest; 2002 Mar; 25(3):RC7-9. PubMed ID: 11936476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
